Your browser doesn't support javascript.
loading
Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study.
Kevlicius, Lukas; Sablauskas, Karolis; Maneikis, Kazimieras; Juozapaite, Dovile; Ringeleviciute, Ugne; Vaitekenaite, Vilmante; Davainiene, Birute; Daukelaite, Guoda; Vasilevska, Dominika; Stoskus, Mindaugas; Narkeviciute, Ieva; Sivickiene, Violeta; Rudaitis, Kestutis; Minkauskas, Mantas; Naumovas, Daniel; Beinortas, Tumas; Griskevicius, Laimonas.
  • Kevlicius L; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Sablauskas K; Hematology and Oncology Department, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
  • Maneikis K; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Juozapaite D; Hematology and Oncology Department, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
  • Ringeleviciute U; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Vaitekenaite V; Hematology and Oncology Department, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
  • Davainiene B; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Daukelaite G; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Vasilevska D; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Stoskus M; Hematology and Oncology Department, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
  • Narkeviciute I; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Sivickiene V; Hematology and Oncology Department, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
  • Rudaitis K; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Minkauskas M; Hematology and Oncology Department, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
  • Naumovas D; Hematology and Oncology Department, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
  • Beinortas T; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Griskevicius L; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Br J Haematol ; 204(2): 497-506, 2024 02.
Article en En | MEDLINE | ID: mdl-37786970
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article